SKIN5:Volunteer Assignments and Opportunities: Difference between revisions
Jump to navigation
Jump to search
| [checked revision] | [checked revision] |
Created page with "Welcome! For assignments, please see the "Author" column below (highlighted blue). If empty (no name is present), please volunteer to create content for that disease! To vo..." |
No edit summary |
||
| (2 intermediate revisions by the same user not shown) | |||
| Line 6: | Line 6: | ||
To volunteer, please '''[[Mailto:CCGA@cancergenomics.org <u>Contact us</u>]]''' with your page of interest. | To volunteer, please '''[[Mailto:CCGA@cancergenomics.org <u>Contact us</u>]]''' with your page of interest. | ||
__TOC__ | |||
<br /> | |||
{| class="wikitable" style="margin:auto" | {| class="wikitable" style="margin:auto" | ||
|+<big>WHO Classification of Skin Tumours (5th Edition) Content</big> | |+<big>WHO Classification of Skin Tumours (5th Edition) Content</big> | ||
| Line 17: | Line 19: | ||
!'''Notes''' | !'''Notes''' | ||
|- | |- | ||
| | |||
==== CHAPTER 2 (KERATINOCYTIC/EPIDERMAL TUMOURS) ==== | |||
| | |||
---- | |||
| | |||
---- | |||
| | |||
---- | |||
| | |||
---- | |||
| | |||
---- | |||
| | |||
---- | |||
| | |||
---- | |||
| | |||
---- | |||
| | |||
---- | |||
|- | |||
|[[SKIN5:Actinic_keratosis|Actinic keratosis]] | |||
|Disease | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|[[SKIN5:Arsenical_keratosis|Arsenical keratosis]] | |||
|Disease | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|[[SKIN5:PUVA_keratosis|PUVA keratosis]] | |||
|Disease | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|[[SKIN5:Squamous_cell_carcinoma_in_situ_(Bowen_disease)|Squamous cell carcinoma in situ (Bowen disease)]] | |||
|Disease | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|[[SKIN5:Verruca_vulgaris|Verruca vulgaris]] | |||
|Disease | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|[[SKIN5:Verruca_plantaris_and_palmaris|Verruca plantaris and palmaris]] | |||
|Disease | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|[[SKIN5:Verruca_plana|Verruca plana]] | |||
|Disease | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|[[SKIN5:Seborrhoeic_keratosis|Seborrhoeic keratosis]] | |||
|Disease | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|[[SKIN5:Solar_lentigo|Solar lentigo]] | |||
|Disease | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|[[SKIN5:Lichen_planus-like_keratosis|Lichen planus-like keratosis]] | |||
|Disease | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|[[SKIN5:Clear_cell_acanthoma|Clear cell acanthoma]] | |||
|Disease | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|[[SKIN5:Large_cell_acanthoma|Large cell acanthoma]] | |||
|Disease | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|[[SKIN5:Warty_dyskeratoma|Warty dyskeratoma]] | |||
|Disease | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|[[SKIN5:Other_benign_keratoses|Other benign keratoses]] | |||
|Disease | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|[[SKIN5:Basal_cell_carcinomas|Basal cell carcinomas]] | |||
|Disease (OVERVIEW?) | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|[[SKIN5:Superficial_basal_cell_carcinoma|Superficial basal cell carcinoma]] | |||
|Disease | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|[[SKIN5:Nodular_basal_cell_carcinoma|Nodular basal cell carcinoma]] | |||
|Disease | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|[[SKIN5:Micronodular_basal_cell_carcinoma|Micronodular basal cell carcinoma]] | |||
|Disease | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|[[SKIN5:Infiltrating_basal_cell_carcinoma|Infiltrating basal cell carcinoma]] | |||
|Disease | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|[[SKIN5:Sclerosing/morphoeic_basal_cell_carcinoma|Sclerosing/morphoeic basal cell carcinoma]] | |||
|Disease | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|[[SKIN5:Basosquamous_carcinoma|Basosquamous carcinoma]] | |||
|Disease | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|[[SKIN5:Basal_cell_carcinoma_with_sarcomatoid_differentiation|Basal cell carcinoma with sarcomatoid differentiation]] | |||
|Disease | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|[[SKIN5:Basal_cell_carcinoma_with_adnexal_differentiation|Basal cell carcinoma with adnexal differentiation]] | |||
|Disease | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|[[SKIN5:Fibroepithelial_basal_cell_carcinoma|Fibroepithelial basal cell carcinoma]] | |||
|Disease | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|[[SKIN5:Keratoacanthoma|Keratoacanthoma]] | |||
|Disease | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|[[SKIN5:Squamous_cell_carcinomas|Squamous cell carcinomas]] | |||
|Disease (OVERVIEW?) | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|[[SKIN5:Verrucous_squamous_cell_carcinoma|Verrucous squamous cell carcinoma]] | |||
|Disease | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|[[SKIN5:Acantholytic_squamous_cell_carcinoma|Acantholytic squamous cell carcinoma]] | |||
|Disease | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|[[SKIN5:Lymphoepithelial_carcinoma|Lymphoepithelial carcinoma]] | |||
|Disease | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|[[SKIN5:Clear_cell_squamous_cell_carcinoma|Clear cell squamous cell carcinoma]] | |||
|Disease | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|[[SKIN5:Spindle_cell_squamous_cell_carcinoma|Spindle cell squamous cell carcinoma]] | |||
|Disease | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|[[SKIN5:Squamous_cell_carcinoma_with_sarcomatoid_differentiation|Squamous cell carcinoma with sarcomatoid differentiation]] | |||
|Disease | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|[[SKIN5:Merkel_cell_carcinoma|Merkel cell carcinoma]] | |||
|Disease | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
| | |||
==== CHAPTER 3 (MELANOCYTIC TUMOURS) ==== | |||
| | |||
---- | |||
| | |||
---- | |||
| | |||
---- | |||
| | |||
---- | |||
| | |||
---- | |||
| | |||
---- | |||
| | |||
---- | |||
| | |||
---- | |||
| | |||
---- | |||
|- | |||
|[[SKIN5:Junctional,_compound,_and_dermal_naevi|Junctional, compound, and dermal naevi]] | |||
|Disease | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|[[SKIN5:Simple_lentigo_and_lentiginous_melanocytic_naevus|Simple lentigo and lentiginous melanocytic naevus]] | |||
|Disease | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|[[SKIN5:Dysplastic_naevus|Dysplastic naevus]] | |||
|Disease | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|[[SKIN5:Naevus_spilus|Naevus spilus]] | |||
|Disease | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |- | ||
| ||Disease | |[[SKIN5:Special-site_naevi_(of_the_breast,_axilla,_scalp,_and_ear)|Special-site naevi (of the breast, axilla, scalp, and ear)]] | ||
|Disease | |||
| | |||
| | | | ||
| | | | ||
| Line 27: | Line 479: | ||
| | | | ||
|- | |- | ||
| ||Disease | |[[SKIN5:Halo_naevus|Halo naevus]] | ||
|Disease | |||
| | |||
| | | | ||
| | | | ||
| Line 36: | Line 490: | ||
| | | | ||
|- | |- | ||
| ||Disease | |[[SKIN5:Meyerson_naevus|Meyerson naevus]] | ||
|Disease | |||
| | |||
| | | | ||
| | | | ||
| Line 45: | Line 501: | ||
| | | | ||
|- | |- | ||
| ||Disease | |[[SKIN5:Recurrent_naevus|Recurrent naevus]] | ||
|Disease | |||
| | |||
| | | | ||
| | | | ||
| Line 54: | Line 512: | ||
| | | | ||
|- | |- | ||
| ||Disease | |[[SKIN5:Combined_naevus|Combined naevus]] | ||
|Disease | |||
| | |||
| | | | ||
| | | | ||
| Line 63: | Line 523: | ||
| | | | ||
|- | |- | ||
| ||Disease | |[[SKIN5:WNT-activated_deep_penetrating/plexiform_melanocytoma_(naevus)|WNT-activated deep penetrating/plexiform melanocytoma (naevus)]] | ||
|Disease | |||
| | |||
| | | | ||
| | | | ||
| Line 72: | Line 534: | ||
| | | | ||
|- | |- | ||
| ||Disease | |[[SKIN5:Pigmented_epithelioid_melanocytoma|Pigmented epithelioid melanocytoma]] | ||
|Disease | |||
| | |||
| | | | ||
| | | | ||
| Line 81: | Line 545: | ||
| | | | ||
|- | |- | ||
| ||Disease | |[[SKIN5:BAP1-inactivated_melanocytoma|BAP1-inactivated melanocytoma]] | ||
|Disease | |||
| | |||
| | | | ||
| | | | ||
| Line 90: | Line 556: | ||
| | | | ||
|- | |- | ||
| ||Disease | |[[SKIN5:MITF_pathway-activated_melanocytic_tumours|MITF pathway-activated melanocytic tumours]] | ||
|Disease | |||
| | |||
| | | | ||
| | | | ||
| Line 99: | Line 567: | ||
| | | | ||
|- | |- | ||
| ||Disease | |[[SKIN5:Low-CSD_melanoma_(including_superficial_spreading_melanoma)|Low-CSD melanoma (including superficial spreading melanoma)]] | ||
|Disease | |||
| | |||
| | | | ||
| | | | ||
| Line 108: | Line 578: | ||
| | | | ||
|- | |- | ||
| ||Disease | |[[SKIN5:Lentigo_maligna_melanoma|Lentigo maligna melanoma]] | ||
|Disease | |||
| | |||
| | | | ||
| | | | ||
| Line 117: | Line 589: | ||
| | | | ||
|- | |- | ||
| ||Disease | |[[SKIN5:Desmoplastic_melanoma|Desmoplastic melanoma]] | ||
|Disease | |||
| | |||
| | | | ||
| | | | ||
| Line 126: | Line 600: | ||
| | | | ||
|- | |- | ||
| ||Disease | |[[SKIN5:Pigmented_spindle_cell_naevus_(Reed_naevus)|Pigmented spindle cell naevus (Reed naevus)]] | ||
|Disease | |||
| | |||
| | | | ||
| | | | ||
| Line 135: | Line 611: | ||
| | | | ||
|- | |- | ||
| ||Disease | |[[SKIN5:Spitz_naevus|Spitz naevus]] | ||
|Disease | |||
| | |||
| | | | ||
| | | | ||
| Line 144: | Line 622: | ||
| | | | ||
|- | |- | ||
| ||Disease | |[[SKIN5:Spitz_melanocytoma_(Atypical_Spitz_tumour)|Spitz melanocytoma (Atypical Spitz tumour)]] | ||
|Disease | |||
| | |||
| | | | ||
| | | | ||
| Line 153: | Line 633: | ||
| | | | ||
|- | |- | ||
| ||Disease | |[[SKIN5:Spitz_melanoma|Spitz melanoma]] | ||
|Disease | |||
| | |||
| | | | ||
| | | | ||
| Line 162: | Line 644: | ||
| | | | ||
|- | |- | ||
| ||Disease | |[[SKIN5:Acral_naevus|Acral naevus]] | ||
|Disease | |||
| | |||
| | | | ||
| | | | ||
| Line 171: | Line 655: | ||
| | | | ||
|- | |- | ||
| ||Disease | |[[SKIN5:Acral_melanoma|Acral melanoma]] | ||
|Disease | |||
| | |||
| | | | ||
| | | | ||
| Line 180: | Line 666: | ||
| | | | ||
|- | |- | ||
| ||Disease | |[[SKIN5:Melanosis|Melanosis]] | ||
|Disease | |||
| | |||
| | | | ||
| | | | ||
| Line 189: | Line 677: | ||
| | | | ||
|- | |- | ||
| ||Disease | |[[SKIN5:Genital_naevus|Genital naevus]] | ||
|Disease | |||
| | |||
| | | | ||
| | | | ||
| Line 198: | Line 688: | ||
| | | | ||
|- | |- | ||
| ||Disease | |[[SKIN5:Mucosal_melanomas|Mucosal melanomas]] | ||
|Disease | |||
| | |||
| | | | ||
| | | | ||
| Line 207: | Line 699: | ||
| | | | ||
|- | |- | ||
| ||Disease | |[[SKIN5:Naevus_of_Ito_and_naevus_of_Ota|Naevus of Ito and naevus of Ota]] | ||
|Disease | |||
| | |||
| | | | ||
| | | | ||
| Line 216: | Line 710: | ||
| | | | ||
|- | |- | ||
| ||Disease|| | |[[SKIN5:Congenital_dermal_melanocytosis|Congenital dermal melanocytosis]] | ||
|Disease | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|[[SKIN5:Blue_naevus|Blue naevus]] | |||
|Disease | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|[[SKIN5:Melanoma_arising_in_blue_naevus|Melanoma arising in blue naevus]] | |||
|Disease | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|[[SKIN5:Congenital_melanocytic_naevus|Congenital melanocytic naevus]] | |||
|Disease | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|[[SKIN5:Proliferative_nodules_in_congenital_melanocytic_naevus|Proliferative nodules in congenital melanocytic naevus]] | |||
|Disease | |||
| | |||
| | | | ||
| | | | ||
| Line 225: | Line 765: | ||
| | | | ||
|- | |- | ||
| ||Disease | |[[SKIN5:Melanoma_arising_in_giant_congenital_naevus|Melanoma arising in giant congenital naevus]] | ||
|Disease | |||
| | |||
| | | | ||
| | | | ||
| Line 234: | Line 776: | ||
| | | | ||
|- | |- | ||
| ||Disease | |[[SKIN5:Conjunctival_naevus|Conjunctival naevus]] | ||
|Disease | |||
| | |||
| | | | ||
| | | | ||
| Line 243: | Line 787: | ||
| | | | ||
|- | |- | ||
| ||Disease | |[[SKIN5:Conjunctival_melanocytic_intraepithelial_lesions|Conjunctival melanocytic intraepithelial lesions]] | ||
|Disease | |||
| | |||
| | | | ||
| | | | ||
| Line 252: | Line 798: | ||
| | | | ||
|- | |- | ||
| ||Disease | |[[SKIN5:Conjunctival_melanoma|Conjunctival melanoma]] | ||
|Disease | |||
| | |||
| | | | ||
| | | | ||
| Line 261: | Line 809: | ||
| | | | ||
|- | |- | ||
| ||Disease | |[[SKIN5:Uveal_melanocytoma|Uveal melanocytoma]] | ||
|Disease | |||
| | |||
| | | | ||
| | | | ||
| Line 270: | Line 820: | ||
| | | | ||
|- | |- | ||
| ||Disease | |[[SKIN5:Uveal_melanoma|Uveal melanoma]] | ||
|Disease | |||
| | |||
| | | | ||
| | | | ||
| Line 279: | Line 831: | ||
| | | | ||
|- | |- | ||
| ||Disease | |[[SKIN5:Diffuse_meningeal_melanocytic_neoplasms:_melanocytosis_and_melanomatosis|Diffuse meningeal melanocytic neoplasms: melanocytosis and melanomatosis]] | ||
|Disease | |||
| | |||
| | | | ||
| | | | ||
| Line 288: | Line 842: | ||
| | | | ||
|- | |- | ||
| ||Disease | |[[SKIN5:Circumscribed_meningeal_melanocytic_neoplasms:_melanocytoma_and_melanoma|Circumscribed meningeal melanocytic neoplasms: melanocytoma and melanoma]] | ||
|Disease | |||
| | |||
| | | | ||
| | | | ||
| Line 297: | Line 853: | ||
| | | | ||
|- | |- | ||
| ||Disease | |[[SKIN5:Nodular_melanoma|Nodular melanoma]] | ||
|Disease | |||
| | |||
| | | | ||
| | | | ||
| Line 306: | Line 864: | ||
| | | | ||
|- | |- | ||
| ||Disease | |[[SKIN5:Naevoid_melanoma|Naevoid melanoma]] | ||
|Disease | |||
| | |||
| | | | ||
| | | | ||
| Line 315: | Line 875: | ||
| | | | ||
|- | |- | ||
| ||Disease | |[[SKIN5:Dermal_melanoma|Dermal melanoma]] | ||
|Disease | |||
| | |||
| | | | ||
| | | | ||
| Line 324: | Line 886: | ||
| | | | ||
|- | |- | ||
| ||Disease | |[[SKIN5:Melanoma_metastatic_to_the_skin|Melanoma metastatic to the skin]] | ||
|Disease | |||
| | |||
| | | | ||
| | | | ||
| Line 333: | Line 897: | ||
| | | | ||
|- | |- | ||
| ||Disease | |[[SKIN5:Melanoma_metastatic_to_other_organs|Melanoma metastatic to other organs]] | ||
|Disease | |||
| | |||
| | | | ||
| | | | ||
| Line 342: | Line 908: | ||
| | | | ||
|- | |- | ||
| | | | ||
==== CHAPTER 4 (APPENDAGEAL TUMOURS) ==== | |||
| | |||
---- | |||
| | |||
---- | |||
| | |||
---- | |||
| | | | ||
---- | |||
| | | | ||
---- | |||
| | | | ||
---- | |||
| | | | ||
---- | |||
| | | | ||
---- | |||
| | | | ||
---- | |||
|- | |- | ||
| ||Disease | |[[SKIN5:Hidrocystoma/cystadenoma|Hidrocystoma/cystadenoma]] | ||
|Disease | |||
| | |||
| | | | ||
| | | | ||
| Line 360: | Line 940: | ||
| | | | ||
|- | |- | ||
| ||Disease | |[[SKIN5:Syringoma|Syringoma]] | ||
|Disease | |||
| | |||
| | | | ||
| | | | ||
| Line 369: | Line 951: | ||
| | | | ||
|- | |- | ||
| ||Disease | |[[SKIN5:Poroma|Poroma]] | ||
|Disease | |||
| | |||
| | | | ||
| | | | ||
| Line 378: | Line 962: | ||
| | | | ||
|- | |- | ||
| ||Disease | |[[SKIN5:Syringofibroadenoma|Syringofibroadenoma]] | ||
|Disease | |||
| | |||
| | | | ||
| | | | ||
| Line 387: | Line 973: | ||
| | | | ||
|- | |- | ||
| ||Disease | |[[SKIN5:Hidradenoma|Hidradenoma]] | ||
|Disease | |||
| | |||
| | | | ||
| | | | ||
| Line 396: | Line 984: | ||
| | | | ||
|- | |- | ||
| ||Disease | |[[SKIN5:Spiradenoma|Spiradenoma]] | ||
|Disease | |||
| | |||
| | | | ||
| | | | ||
| Line 405: | Line 995: | ||
| | | | ||
|- | |- | ||
| ||Disease | |[[SKIN5:Cylindroma|Cylindroma]] | ||
|Disease | |||
| | |||
| | | | ||
| | | | ||
| Line 414: | Line 1,006: | ||
| | | | ||
|- | |- | ||
| ||Disease | |[[SKIN5:Tubular_adenoma|Tubular adenoma]] | ||
|Disease | |||
| | |||
| | | | ||
| | | | ||
| Line 423: | Line 1,017: | ||
| | | | ||
|- | |- | ||
| ||Disease | |[[SKIN5:Syringocystadenoma_papilliferum|Syringocystadenoma papilliferum]] | ||
|Disease | |||
| | |||
| | | | ||
| | | | ||
| Line 432: | Line 1,028: | ||
| | | | ||
|- | |- | ||
| ||Disease | |[[SKIN5:Mixed_tumour|Mixed tumour]] | ||
|Disease | |||
| | |||
| | | | ||
| | | | ||
| Line 441: | Line 1,039: | ||
| | | | ||
|- | |- | ||
| ||Disease | |[[SKIN5:Myoepithelioma|Myoepithelioma]] | ||
|Disease | |||
| | |||
| | | | ||
| | | | ||
| Line 450: | Line 1,050: | ||
| | | | ||
|- | |- | ||
| ||Disease | |[[SKIN5:Adnexal_adenocarcinoma,_NOS|Adnexal adenocarcinoma, NOS]] | ||
|Disease | |||
| | |||
| | | | ||
| | | | ||
| Line 459: | Line 1,061: | ||
| | | | ||
|- | |- | ||
| ||Disease | |[[SKIN5:Microcystic_adnexal_carcinoma|Microcystic adnexal carcinoma]] | ||
|Disease | |||
| | |||
| | | | ||
| | | | ||
| Line 468: | Line 1,072: | ||
| | | | ||
|- | |- | ||
| ||Disease | |[[SKIN5:Cribriform_tumour_(previously_carcinoma)|Cribriform tumour (previously carcinoma)]] | ||
|Disease | |||
| | |||
| | | | ||
| | | | ||
| Line 477: | Line 1,083: | ||
| | | | ||
|- | |- | ||
| ||Disease | |[[SKIN5:Porocarcinoma|Porocarcinoma]] | ||
|Disease | |||
| | |||
| | | | ||
| | | | ||
| Line 486: | Line 1,094: | ||
| | | | ||
|- | |- | ||
| ||Disease | |[[SKIN5:NUT_carcinoma|NUT carcinoma]] | ||
|Disease | |||
| | |||
| | | | ||
| | | | ||
| Line 495: | Line 1,105: | ||
| | | | ||
|- | |- | ||
| ||Disease | |[[SKIN5:Malignant_neoplasms_arising_from_spiradenoma,_cylindroma,_or_spiradenocylindroma|Malignant neoplasms arising from spiradenoma, cylindroma, or spiradenocylindroma]] | ||
|Disease | |||
| | |||
| | | | ||
| | | | ||
| Line 504: | Line 1,116: | ||
| | | | ||
|- | |- | ||
| ||Disease | |[[SKIN5:Malignant_mixed_tumour|Malignant mixed tumour]] | ||
|Disease | |||
| | |||
| | | | ||
| | | | ||
| Line 513: | Line 1,127: | ||
| | | | ||
|- | |- | ||
| ||Disease | |[[SKIN5:Hidradenocarcinoma|Hidradenocarcinoma]] | ||
|Disease | |||
| | |||
| | | | ||
| | | | ||
| Line 522: | Line 1,138: | ||
| | | | ||
|- | |- | ||
| ||Disease | |[[SKIN5:Endocrine_mucin-producing_sweat_gland_carcinoma|Endocrine mucin-producing sweat gland carcinoma]] | ||
|Disease | |||
| | |||
| | | | ||
| | | | ||
| Line 531: | Line 1,149: | ||
| | | | ||
|- | |- | ||
| ||Disease | |[[SKIN5:Mucinous_carcinoma|Mucinous carcinoma]] | ||
|Disease | |||
| | |||
| | | | ||
| | | | ||
| Line 540: | Line 1,160: | ||
| | | | ||
|- | |- | ||
| ||Disease | |[[SKIN5:Digital_papillary_adenocarcinoma|Digital papillary adenocarcinoma]] | ||
|Disease | |||
| | |||
| | | | ||
| | | | ||
| Line 549: | Line 1,171: | ||
| | | | ||
|- | |- | ||
| ||Disease | |[[SKIN5:Adenoid_cystic_carcinoma|Adenoid cystic carcinoma]] | ||
|Disease | |||
| | |||
| | | | ||
| | | | ||
| Line 558: | Line 1,182: | ||
| | | | ||
|- | |- | ||
| ||Disease | |[[SKIN5:Apocrine_carcinoma|Apocrine carcinoma]] | ||
|Disease | |||
| | |||
| | | | ||
| | | | ||
| Line 567: | Line 1,193: | ||
| | | | ||
|- | |- | ||
| ||Disease | |[[SKIN5:Squamoid_ductal_eccrine_carcinoma|Squamoid ductal eccrine carcinoma]] | ||
|Disease | |||
| | |||
| | | | ||
| | | | ||
| Line 576: | Line 1,204: | ||
| | | | ||
|- | |- | ||
| ||Disease | |[[SKIN5:Syringocystadenocarcinoma_papilliferum|Syringocystadenocarcinoma papilliferum]] | ||
|Disease | |||
| | |||
| | | | ||
| | | | ||
| Line 585: | Line 1,215: | ||
| | | | ||
|- | |- | ||
| ||Disease | |[[SKIN5:Secretory_carcinoma|Secretory carcinoma]] | ||
|Disease | |||
| | |||
| | | | ||
| | | | ||
| Line 594: | Line 1,226: | ||
| | | | ||
|- | |- | ||
| ||Disease | |[[SKIN5:Signet-ring_cell/histiocytoid_carcinoma|Signet-ring cell/histiocytoid carcinoma]] | ||
|Disease | |||
| | |||
| | | | ||
| | | | ||
| Line 603: | Line 1,237: | ||
| | | | ||
|- | |- | ||
| ||Disease | |[[SKIN5:Trichoblastoma|Trichoblastoma]] | ||
|Disease | |||
| | |||
| | | | ||
| | | | ||
| Line 612: | Line 1,248: | ||
| | | | ||
|- | |- | ||
| ||Disease | |[[SKIN5:Pilomatricoma|Pilomatricoma]] | ||
|Disease | |||
| | |||
| | | | ||
| | | | ||
| Line 621: | Line 1,259: | ||
| | | | ||
|- | |- | ||
| ||Disease | |[[SKIN5:Melanocytic_matricoma|Melanocytic matricoma]] | ||
|Disease | |||
| | |||
| | | | ||
| | | | ||
| Line 630: | Line 1,270: | ||
| | | | ||
|- | |- | ||
| ||Disease | |[[SKIN5:Trichilemmoma|Trichilemmoma]] | ||
|Disease | |||
| | |||
| | | | ||
| | | | ||
| Line 639: | Line 1,281: | ||
| | | | ||
|- | |- | ||
| ||Disease | |[[SKIN5:Trichoadenoma|Trichoadenoma]] | ||
|Disease | |||
| | |||
| | | | ||
| | | | ||
| Line 648: | Line 1,292: | ||
| | | | ||
|- | |- | ||
| ||Disease | |[[SKIN5:Trichofolliculoma|Trichofolliculoma]] | ||
|Disease | |||
| | |||
| | | | ||
| | | | ||
| Line 657: | Line 1,303: | ||
| | | | ||
|- | |- | ||
| ||Disease | |[[SKIN5:Pilar_sheath_acanthoma|Pilar sheath acanthoma]] | ||
|Disease | |||
| | |||
| | | | ||
| | | | ||
| Line 666: | Line 1,314: | ||
| | | | ||
|- | |- | ||
| ||Disease | |[[SKIN5:Tumour_of_the_follicular_infundibulum|Tumour of the follicular infundibulum]] | ||
|Disease | |||
| | |||
| | | | ||
| | | | ||
| Line 675: | Line 1,325: | ||
| | | | ||
|- | |- | ||
| ||Disease | |[[SKIN5:Trichodiscomas_and_fibrofolliculomas|Trichodiscomas and fibrofolliculomas]] | ||
|Disease | |||
| | |||
| | | | ||
| | | | ||
| Line 684: | Line 1,336: | ||
| | | | ||
|- | |- | ||
| ||Disease | |[[SKIN5:Proliferating_trichilemmal_tumour|Proliferating trichilemmal tumour]] | ||
|Disease | |||
| | |||
| | | | ||
| | | | ||
| Line 693: | Line 1,347: | ||
| | | | ||
|- | |- | ||
| ||Disease | |[[SKIN5:Pilomatrical_carcinoma|Pilomatrical carcinoma]] | ||
|Disease | |||
| | |||
| | | | ||
| | | | ||
| Line 702: | Line 1,358: | ||
| | | | ||
|- | |- | ||
| ||Disease | |[[SKIN5:Trichoblastic_carcinoma/carcinosarcoma|Trichoblastic carcinoma/carcinosarcoma]] | ||
|Disease | |||
| | |||
| | | | ||
| | | | ||
| Line 711: | Line 1,369: | ||
| | | | ||
|- | |- | ||
| ||Disease | |[[SKIN5:Trichilemmal_carcinoma|Trichilemmal carcinoma]] | ||
|Disease | |||
| | |||
| | | | ||
| | | | ||
| Line 720: | Line 1,380: | ||
| | | | ||
|- | |- | ||
| ||Disease | |[[SKIN5:Sebaceoma|Sebaceoma]] | ||
|Disease | |||
| | |||
| | | | ||
| | | | ||
| Line 729: | Line 1,391: | ||
| | | | ||
|- | |- | ||
| ||Disease | |[[SKIN5:Sebaceous_adenoma|Sebaceous adenoma]] | ||
|Disease | |||
| | |||
| | | | ||
| | | | ||
| Line 738: | Line 1,402: | ||
| | | | ||
|- | |- | ||
|[[SKIN5:Sebaceous_carcinoma|Sebaceous carcinoma]] | |||
|Disease | |||
| | | | ||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|[[SKIN5:Hidradenoma_papilliferum|Hidradenoma papilliferum]] | |||
|Disease | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|[[SKIN5:Fibroadenoma_and_phyllodes_tumour_of_anogenital_mammary-like_glands|Fibroadenoma and phyllodes tumour of anogenital mammary-like glands]] | |||
|Disease | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|[[SKIN5:Mammary_Paget_disease|Mammary Paget disease]] | |||
|Disease | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|[[SKIN5:Extramammary_Paget_disease|Extramammary Paget disease]] | |||
|Disease | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|[[SKIN5:Adenocarcinoma_of_mammary-gland_type|Adenocarcinoma of mammary-gland type]] | |||
|Disease | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
| | |||
==== CHAPTER 5 (TUMOURS OF THE NAIL UNIT) ==== | |||
| | |||
---- | |||
| | |||
---- | |||
| | |||
---- | |||
| | |||
---- | |||
| | |||
---- | |||
| | |||
---- | |||
| | |||
---- | |||
| | |||
---- | |||
| | |||
---- | |||
|- | |||
|[[SKIN5:Onychomatricoma|Onychomatricoma]] | |||
|Disease | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|[[SKIN5:Onychopapilloma|Onychopapilloma]] | |||
|Disease | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|[[SKIN5:Ungual_fibrokeratoma|Ungual fibrokeratoma]] | |||
|Disease | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|[[SKIN5:Onychocytic_matricoma|Onychocytic matricoma]] | |||
|Disease | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|[[SKIN5:Subungual_keratoacathoma|Subungual keratoacathoma]] | |||
|Disease | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
| | |||
==== CHAPTER 6 (TUMOURS OF HAEMATOPOIETIC AND LYMPHOID ORIGIN) ==== | |||
| | |||
---- | |||
| | |||
---- | |||
| | |||
---- | |||
| | |||
---- | |||
| | |||
---- | |||
| | |||
---- | |||
| | |||
---- | |||
| | |||
---- | |||
| | |||
---- | |||
|- | |||
|[[SKIN5:Mastocytosis|Mastocytosis]] | |||
|Disease | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|[[SKIN5:Mast_cell_sarcoma|Mast cell sarcoma]] | |||
|Disease | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|[[SKIN5:Cutaneous_involvement_in_myeloid_neoplasms,_including_myeloid_sarcoma|Cutaneous involvement in myeloid neoplasms, including myeloid sarcoma]] | |||
|Disease | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|[[SKIN5:Mature_plasmacytoid_dendritic_cell_proliferation_associated_with_myeloid_neoplasm|Mature plasmacytoid dendritic cell proliferation associated with myeloid neoplasm]] | |||
|Disease | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|[[SKIN5:Blastic_plasmacytoid_dendritic_cell_neoplasm|Blastic plasmacytoid dendritic cell neoplasm]] | |||
|Disease | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|[[SKIN5:Langerhans_cell_histiocytosis|Langerhans cell histiocytosis]] | |||
|Disease | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|[[SKIN5:Xanthelasma|Xanthelasma]] | |||
|Disease | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|[[SKIN5:Juvenile_xanthogranuloma|Juvenile xanthogranuloma]] | |||
|Disease | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|[[SKIN5:Reticulohistiocytosis|Reticulohistiocytosis]] | |||
|Disease | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|[[SKIN5:Rosai-Dorfman_Disease|Rosai-Dorfman Disease]] | |||
|Disease | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|[[SKIN5:Erdheim-Chester_disease|Erdheim-Chester disease]] | |||
|Disease | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|[[SKIN5:ALK_postive_histiocytosis_|ALK postive histiocytosis]] | |||
|Disease | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|[[SKIN5:Histiocytic_sarcoma|Histiocytic sarcoma]] | |||
|Disease | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|[[SKIN5:Indeterminate_dendritic_cell_tumour|Indeterminate dendritic cell tumour]] | |||
|Disease | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|[[SKIN5:Reactive_B-cell_rich_lymphoid_proliferations|Reactive B-cell rich lymphoid proliferations]] | |||
|Disease | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|[[SKIN5:Primary_cutaneous_marginal_zone_lymphoma|Primary cutaneous marginal zone lymphoma]] | |||
|Disease | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|[[SKIN5:Primary_cutaneous_follicle_centre_lymphoma|Primary cutaneous follicle centre lymphoma]] | |||
|Disease | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|[[SKIN5:Primary_cutaneous_diffuse_large_B-cell_lymphoma,_leg_type|Primary cutaneous diffuse large B-cell lymphoma, leg type]] | |||
|Disease | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|[[SKIN5:Intravascular_large_B-cell_lymphoma|Intravascular large B-cell lymphoma]] | |||
|Disease | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|[[SKIN5:Mantle_cell_lymphoma|Mantle cell lymphoma]] | |||
|Disease | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|[[SKIN5:Burkitt_lymphoma|Burkitt lymphoma]] | |||
|Disease | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|[[SKIN5:Chronic_lymphocytic_leukaemia/small_lymphocytic_lymphoma|Chronic lymphocytic leukaemia/small lymphocytic lymphoma]] | |||
|Disease | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|[[SKIN5:B-lymphoblastic_leukaemia/lymphoma|B-lymphoblastic leukaemia/lymphoma]] | |||
|Disease | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|[[SKIN5:Secondary_lymphomatoid_granulomatosis_|Secondary lymphomatoid granulomatosis]] | |||
|Disease | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|[[SKIN5:Reactive_T-cell_rich_lymphoid_proliferations|Reactive T-cell rich lymphoid proliferations]] | |||
|Disease | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|[[SKIN5:Primary_cutaneous_CD4-positive_small_or_medium_T-cell_lymphoproliferative_disorder|Primary cutaneous CD4-positive small or medium T-cell lymphoproliferative disorder]] | |||
|Disease | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|[[SKIN5:Mycosis_fungoides|Mycosis fungoides]] | |||
|Disease | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|[[SKIN5:Primary_cutaneous_CD30+_T-cell_lymphoproliferative_disorder:_Lymphomatoid_papulosis|Primary cutaneous CD30+ T-cell lymphoproliferative disorder: Lymphomatoid papulosis]] | |||
|Disease | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|[[SKIN5:Primary_cutaneous_CD30+_T-cell_lymphoproliferative_disorder:_Primary_cutaneous_anaplastic_large_cell_lymphoma|Primary cutaneous CD30+ T-cell lymphoproliferative disorder: Primary cutaneous anaplastic large cell lymphoma]] | |||
|Disease | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|[[SKIN5:Subcutaneous_panniculitis-like_T-cell_lymphoma|Subcutaneous panniculitis-like T-cell lymphoma]] | |||
|Disease | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|[[SKIN5:Primary_cutaneous_gamma/delta_T-cell_lymphoma|Primary cutaneous gamma/delta T-cell lymphoma]] | |||
|Disease | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|[[SKIN5:Primary_cutaneous_acral_CD8-positive_T-cell_lymphoproliferative_disorder|Primary cutaneous acral CD8-positive T-cell lymphoproliferative disorder]] | |||
|Disease | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|[[SKIN5:Primary_cutaneous_CD8-positive_aggressive_epidermotropic_cytotoxic_T-cell_lymphoma|Primary cutaneous CD8-positive aggressive epidermotropic cytotoxic T-cell lymphoma]] | |||
|Disease | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|[[SKIN5:Primary_cutaneous_peripheral_T-cell_lymphoma,_NOS|Primary cutaneous peripheral T-cell lymphoma, NOS]] | |||
|Disease | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|[[SKIN5:Sezary_syndrome|Sezary syndrome]] | |||
|Disease | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|[[SKIN5:Severe_mosquito_bite_allergy|Severe mosquito bite allergy]] | |||
|Disease | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|[[SKIN5:Hydroa_vacciniforme_lymphoproliferative_disorder|Hydroa vacciniforme lymphoproliferative disorder]] | |||
|Disease | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|[[SKIN5:Anaplastic_large_cell_lymphoma|Anaplastic large cell lymphoma]] | |||
|Disease | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|[[SKIN5:Nodal_T_follicular_helper_lymphoma,_angioimmunoblastic_type|Nodal T follicular helper lymphoma, angioimmunoblastic type]] | |||
|Disease | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|[[SKIN5:T-cell_prolymphocytic_leukaemia|T-cell prolymphocytic leukaemia]] | |||
|Disease | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|[[SKIN5:T-lymphoblastic_leukaemia/lymphoma|T-lymphoblastic leukaemia/lymphoma]] | |||
|Disease | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|[[SKIN5:Adult_T_cell_leukaemia/lymphoma|Adult T cell leukaemia/lymphoma]] | |||
|Disease | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|[[SKIN5:Extranodal_NK/T-cell_lymphoma|Extranodal NK/T-cell lymphoma]] | |||
|Disease | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|[[SKIN5:EBV-positive_mucocutaneous_ulcer|EBV-positive mucocutaneous ulcer]] | |||
|Disease | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|[[SKIN5:Inborn_error_of_immunity-associated_lymphoproliferative_disorders|Inborn error of immunity-associated lymphoproliferative disorders]] | |||
|Disease | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
| | |||
==== CHAPTER 7 (SOFT TISSUE TUMOURS) ==== | |||
| | |||
---- | |||
| | |||
---- | |||
| | |||
---- | |||
| | |||
---- | |||
| | |||
---- | |||
| | |||
---- | |||
| | |||
---- | |||
| | |||
---- | |||
| | |||
---- | |||
|- | |||
|[[SKIN5:Naevus_lipomatosus_superficialis|Naevus lipomatosus superficialis]] | |||
|Disease | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|[[SKIN5:Lipoma|Lipoma]] | |||
|Disease | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|[[SKIN5:Angiolipoma|Angiolipoma]] | |||
|Disease | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|[[SKIN5:Spindle_cell/pleomorphic_lipoma|Spindle cell/pleomorphic lipoma]] | |||
|Disease | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|[[SKIN5:Atypical_lipomatous_tumour|Atypical lipomatous tumour]] | |||
|Disease | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|[[SKIN5:Pleomorphic_liposarcoma|Pleomorphic liposarcoma]] | |||
|Disease | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|[[SKIN5:Fibroma_of_tendon_sheath|Fibroma of tendon sheath]] | |||
|Disease | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|[[SKIN5:Calcifying_aponeurotic_fibroma|Calcifying aponeurotic fibroma]] | |||
|Disease | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|[[SKIN5:Sclerotic_fibroma|Sclerotic fibroma]] | |||
|Disease | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|[[SKIN5:Nuchal-type_fibroma|Nuchal-type fibroma]] | |||
|Disease | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|[[SKIN5:Gardner_fibroma|Gardner fibroma]] | |||
|Disease | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|[[SKIN5:Pleomorphic_fibroma|Pleomorphic fibroma]] | |||
|Disease | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|[[SKIN5:Elastofibroma|Elastofibroma]] | |||
|Disease | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|[[SKIN5:Desmoplastic_fibroblastoma|Desmoplastic fibroblastoma]] | |||
|Disease | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|[[SKIN5:Fibrous_papule|Fibrous papule]] | |||
|Disease | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|[[SKIN5:Fibroblastic_connective_tissue_naevus|Fibroblastic connective tissue naevus]] | |||
|Disease | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|[[SKIN5:Fibroosseous_tumour_of_digits|Fibroosseous tumour of digits]] | |||
|Disease | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|[[SKIN5:Dermatofibroma_(fibrous_histiocytoma)|Dermatofibroma (fibrous histiocytoma)]] | |||
|Disease | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|[[SKIN5:Superficial_fibromatosis|Superficial fibromatosis]] | |||
|Disease | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|[[SKIN5:Inclusion_body_fibromatosis_|Inclusion body fibromatosis]] | |||
|Disease | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|[[SKIN5:Plexiform_fibrohistiocytic_tumour|Plexiform fibrohistiocytic tumour]] | |||
|Disease | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|[[SKIN5:Superficial_acral_fibromyxoma|Superficial acral fibromyxoma]] | |||
|Disease | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|[[SKIN5:Cutaneous_myxoma_(superficial_angiomyxoma)|Cutaneous myxoma (superficial angiomyxoma)]] | |||
|Disease | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|[[SKIN5:Dermatomyofibroma|Dermatomyofibroma]] | |||
|Disease | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|[[SKIN5:Multinucleate_cell_angiohistiocytoma|Multinucleate cell angiohistiocytoma]] | |||
|Disease | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|[[SKIN5:Plaque-like_CD34+_dermal_fibroma|Plaque-like CD34+ dermal fibroma]] | |||
|Disease | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|[[SKIN5:Nodular_fasciitis|Nodular fasciitis]] | |||
|Disease | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|[[SKIN5:EWSR1::SMAD3_rearranged_fibroblastic_tumour|EWSR1::SMAD3 rearranged fibroblastic tumour]] | |||
|Disease | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|[[SKIN5:Dermatofibrosarcoma_protuberans|Dermatofibrosarcoma protuberans]] | |||
|Disease | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|[[SKIN5:Myxoinflammatory_fibroblastic_sarcoma|Myxoinflammatory fibroblastic sarcoma]] | |||
|Disease | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|[[SKIN5:Myxofibrosarcoma|Myxofibrosarcoma]] | |||
|Disease | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|[[SKIN5:Cherry_haemangioma|Cherry haemangioma]] | |||
|Disease | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|[[SKIN5:Sinusoidal_haemangioma|Sinusoidal haemangioma]] | |||
|Disease | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|[[SKIN5:Microvenular_haemangioma|Microvenular haemangioma]] | |||
|Disease | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|[[SKIN5:Hobnail_haemangioma|Hobnail haemangioma]] | |||
|Disease | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|[[SKIN5:Glomeruloid_haemangioma|Glomeruloid haemangioma]] | |||
|Disease | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|[[SKIN5:Papillary_haemangioma|Papillary haemangioma]] | |||
|Disease | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|[[SKIN5:Spindle_cell_haemangioma|Spindle cell haemangioma]] | |||
|Disease | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|[[SKIN5:Epithelioid_haemangioma|Epithelioid haemangioma]] | |||
|Disease | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|[[SKIN5:Tufted_haemangioma|Tufted haemangioma]] | |||
|Disease | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|[[SKIN5:Angiokeratoma|Angiokeratoma]] | |||
|Disease | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|[[SKIN5:Infantile_haemangioma|Infantile haemangioma]] | |||
|Disease | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|[[SKIN5:Congenital_non-progressive_haemangiomas:_rapidly_involuting_congenital_haemangioma_and_non-involuting_congenital_haemangioma|Congenital non-progressive haemangiomas: rapidly involuting congenital haemangioma and non-involuting congenital haemangioma]] | |||
|Disease | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|[[SKIN5:Lobular_capillary_haemangioma|Lobular capillary haemangioma]] | |||
|Disease | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|[[SKIN5:Poikilodermatous_plaque-like_haemangioma|Poikilodermatous plaque-like haemangioma]] | |||
|Disease | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|[[SKIN5:Acquired_elastotic_haemangioma|Acquired elastotic haemangioma]] | |||
|Disease | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|[[SKIN5:Verrucous_venous_malformation|Verrucous venous malformation]] | |||
|Disease | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|[[SKIN5:Arteriovenous_malformation|Arteriovenous malformation]] | |||
|Disease | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|[[SKIN5:Lymphangioma_(superficial_lymphatic_malformation)|Lymphangioma (superficial lymphatic malformation)]] | |||
|Disease | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|[[SKIN5:Cutaneous_epithelioid_angiomatous_nodule|Cutaneous epithelioid angiomatous nodule]] | |||
|Disease | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|[[SKIN5:Post-radiation_atypical_vascular_lesion|Post-radiation atypical vascular lesion]] | |||
|Disease | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|[[SKIN5:Pseudomyogenic_haemangioendothelioma|Pseudomyogenic haemangioendothelioma]] | |||
|Disease | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|[[SKIN5:Epithelioid_haemangioendothelioma|Epithelioid haemangioendothelioma]] | |||
|Disease | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|[[SKIN5:Hobnail_haemangioendotheliomas|Hobnail haemangioendotheliomas]] | |||
|Disease | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|[[SKIN5:Composite_haemangioendothelioma_|Composite haemangioendothelioma]] | |||
|Disease | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|[[SKIN5:Kaposi_sarcoma|Kaposi sarcoma]] | |||
|Disease | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|[[SKIN5:Cutaneous_angiosarcoma|Cutaneous angiosarcoma]] | |||
|Disease | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|[[SKIN5:Glomus_tumour|Glomus tumour]] | |||
|Disease | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|[[SKIN5:Myopericytoma|Myopericytoma]] | |||
|Disease | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|[[SKIN5:Myofibroma_and_myofibromatosis|Myofibroma and myofibromatosis]] | |||
|Disease | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|[[SKIN5:Angioleiomyoma|Angioleiomyoma]] | |||
|Disease | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|[[SKIN5:Smooth_muscle_hamartoma|Smooth muscle hamartoma]] | |||
|Disease | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|[[SKIN5:Cutaneous_leiomyomas|Cutaneous leiomyomas]] | |||
|Disease | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|[[SKIN5:EBV-associated_smooth_muscle_tumour|EBV-associated smooth muscle tumour]] | |||
|Disease | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|[[SKIN5:Atypical_intradermal_smooth_muscle_neoplasm|Atypical intradermal smooth muscle neoplasm]] | |||
|Disease | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|[[SKIN5:Dermal_hyperneury/Epithelial_sheath_neuroma|Dermal hyperneury/Epithelial sheath neuroma]] | |||
|Disease | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|[[SKIN5:Solitary_circumscribed_neuroma|Solitary circumscribed neuroma]] | |||
|Disease | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|[[SKIN5:Dermal_nerve_sheath_myxoma|Dermal nerve sheath myxoma]] | |||
|Disease | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|[[SKIN5:Perineurioma|Perineurioma]] | |||
|Disease | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|[[SKIN5:Neurofibroma|Neurofibroma]] | |||
|Disease | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|[[SKIN5:Schwannoma|Schwannoma]] | |||
|Disease | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|[[SKIN5:Granular_cell_tumour|Granular cell tumour]] | |||
|Disease | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|[[SKIN5:Hybrid_nerve_sheath_tumours_|Hybrid nerve sheath tumours]] | |||
|Disease | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|[[SKIN5:Malignant_peripheral_nerve_sheath_tumour|Malignant peripheral nerve sheath tumour]] | |||
|Disease | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|[[SKIN5:Cellular_neurothekeoma|Cellular neurothekeoma]] | |||
|Disease | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|[[SKIN5:Epithelioid_fibrous_histiocytoma|Epithelioid fibrous histiocytoma]] | |||
|Disease | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|[[SKIN5:Non-neural_granular_cell_tumour|Non-neural granular cell tumour]] | |||
|Disease | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|[[SKIN5:PEComa_|PEComa]] | |||
|Disease | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|[[SKIN5:Angiomatoid_fibrous_histiocytoma_|Angiomatoid fibrous histiocytoma]] | |||
|Disease | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|[[SKIN5:NTRK-rearranged_spindle_cell_neoplasm|NTRK-rearranged spindle cell neoplasm]] | |||
|Disease | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|[[SKIN5:Atypical_fibroxanthoma|Atypical fibroxanthoma]] | |||
|Disease | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|[[SKIN5:Superficial_CD34+_fibroblastic_tumour|Superficial CD34+ fibroblastic tumour]] | |||
|Disease | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|[[SKIN5:Pleomorphic_dermal_sarcoma|Pleomorphic dermal sarcoma]] | |||
|Disease | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|[[SKIN5:Epithelioid_sarcoma|Epithelioid sarcoma]] | |||
|Disease | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|[[SKIN5:CRTC1::TRIM11_cutaneous_tumour|CRTC1::TRIM11 cutaneous tumour]] | |||
|Disease | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|[[SKIN5:Dermal_clear_cell_sarcoma|Dermal clear cell sarcoma]] | |||
|Disease | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|[[SKIN5:Ewing_sarcoma|Ewing sarcoma]] | |||
|Disease | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
| | |||
==== CHAPTER 8 (METASTASES TO SKIN) ==== | |||
| | |||
---- | |||
| | |||
---- | |||
| | |||
---- | |||
| | |||
---- | |||
| | |||
---- | |||
| | |||
---- | |||
| | |||
---- | |||
| | |||
---- | |||
| | |||
---- | |||
|- | |||
|[[SKIN5:Metastases_to_skin|Metastases to skin]] | |||
|Disease | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|[[SKIN5:Cancer_of_unknown_primary_site|Cancer of unknown primary site]] | |||
|Disease | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
| | |||
==== CHAPTER 9 (GENETIC TUMOUR SYNDROMES ASSOCIATED WITH SKIN MALIGNANCIES) ==== | |||
| | |||
---- | |||
| | |||
---- | |||
| | |||
---- | |||
| | |||
---- | |||
| | |||
---- | |||
| | |||
---- | |||
| | |||
---- | |||
| | |||
---- | |||
| | |||
---- | |||
|- | |||
|[[SKIN5:Familial_melanoma|Familial melanoma]] | |||
|Disease | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|[[SKIN5:BAP1_tumour_predisposition_syndrome|BAP1 tumour predisposition syndrome]] | |||
|Disease | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|[[SKIN5:Xeroderma_pigmentosum|Xeroderma pigmentosum]] | |||
|Disease | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|[[SKIN5:Naevoid_basal_cell_carcinoma_syndrome_(Gorlin_syndrome)|Naevoid basal cell carcinoma syndrome (Gorlin syndrome)]] | |||
|Disease | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|[[SKIN5:Carney_complex|Carney complex]] | |||
|Disease | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|[[SKIN5:Muir-Torre_syndrome|Muir-Torre syndrome]] | |||
|Disease | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|[[SKIN5:Brooke-Spiegler_and_related_syndromes|Brooke-Spiegler and related syndromes]] | |||
|Disease | |Disease | ||
| | | | ||
Latest revision as of 14:05, 10 September 2024
Welcome!
For assignments, please see the "Author" column below (highlighted blue).
If empty (no name is present), please volunteer to create content for that disease!
To volunteer, please [Contact us] with your page of interest.